Effect of Anti–Vascular Endothelial Growth Factor Therapy on Choroidal Thickness in Diabetic Macular Edema

• Published in: American journal of ophthalmology Vol. 158; no. 4; pp. 745 - 751.e2
• Main Authors: Yiu, Glenn, Manjunath, Varsha, Chiu, Stephanie J., Farsiu, Sina, Mahmoud, Tamer H.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.10.2014; Elsevier Limited
• Subjects: Angiogenesis Inhibitors - therapeutic use; Choroid - pathology; Cohort Studies; Diabetic Retinopathy - drug therapy; Female; Humans; Intravitreal Injections; Macular degeneration; Macular Edema - drug therapy; Male; Middle Aged; Ophthalmology; Organ Size; Pharmaceutical industry; Retrospective Studies; Studies; Tomography, Optical Coherence; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity - physiology

To determine the effect of anti–vascular endothelial growth factor (VEGF) therapy on choroidal thickness in eyes with diabetic macular edema (DME). A retrospective, cohort analysis of 59 eyes from 59 patients with DME without prior anti-VEGF therapy. Choroidal thickness was measured using semiautoma...